ENTRY       D12315                      Drug
NAME        Ciltacabtagene autoleucel (USAN/INN);
            Carvykti (TN);
            Carvykti (TN)
PRODUCT     CARVYKTI (Janssen Biotech)
REMARK      ATC code: L01XL05
            Product: D12315<US>
EFFICACY    Antineoplastic
  DISEASE   Multiple myeloma [DS:H00010]
  TYPE      Cellular therapy product, CAR-T cell therapy
COMMENT     Treatment of multiple myeloma
TARGET      TNFRSF17 (BCMA, CD269) [HSA:608] [KO:K05153]
            CD38 [HSA:952] [KO:K01242]
  PATHWAY   hsa04060(608)  Cytokine-cytokine receptor interaction
            hsa04640(952)  Hematopoietic cell lineage
            hsa04672(608)  Intestinal immune network for IgA production
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01X OTHER ANTINEOPLASTIC AGENTS
                L01XL Antineoplastic cell and gene therapy
                 L01XL05 Ciltacabtagene autoleucel
                  D12315  Ciltacabtagene autoleucel (USAN/INN) &lt;US&gt;
            Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Tumor necrosis factor receptors
                TNFRSF17 (BCMA, CD269)
                 D12315  Ciltacabtagene autoleucel (USAN/INN) &lt;US&gt;
             Enzymes
              Hydrolases (EC3)
               ADP-ribosyl cyclase
                CD38
                 D12315  Ciltacabtagene autoleucel (USAN/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             Cellular and gene therapy products
              D12315
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D12315
            New drug approvals in Japan [br08318.html]
             Cellular and gene therapy products
              D12315
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D12315
///
